Yihan Li
Stock Analyst at Barclays
(2.85)
# 2,679
Out of 4,423 analysts
40
Total ratings
75%
Success rate
12.7%
Average return
Main Sectors:
Stocks Rated by Yihan Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | $156.50 | +8.63% | 12 | May 19, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $86 → $65 | $44.75 | +45.74% | 2 | May 11, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 155.00 | $172.40 | -10.09% | 21 | Dec 8, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 375.00 | $293.31 | +27.85% | 2 | Nov 28, 2025 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 275.00 | $319.80 | -14.01% | 3 | Oct 24, 2025 |
Ipsen S.A.
May 19, 2026
Maintained: Hold
Price Target: €170.00
Current: $156.50
Upside: +8.63%
Zealand Pharma A/S
May 11, 2026
Maintained: Buy
Price Target: $86 → $65
Current: $44.75
Upside: +45.74%
Galderma Group AG
Dec 8, 2025
Maintained: Buy
Price Target: CHF 155.00
Current: $172.40
Upside: -10.09%
Novo Nordisk A/S
Nov 28, 2025
Maintained: Hold
Price Target: kr 375.00
Current: $293.31
Upside: +27.85%
Roche Holding AG
Oct 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $319.80
Upside: -14.01%